Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Cyclo Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 9 | 12 | +3 |
| Shares | 71.4K | 263.7K | +192.3K (+269.3%) |
| Value | $585.0K | $2.70M | +$2.11M (+360.9%) |
New holders (4)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 44,700 | $457.0K | 0.00% |
| BlackRock Inc. | 10,844 | $111.0K | 0.00% |
| Advisory Services Network, LLC | 100 | $1.00K | 0.00% |
| IFP Advisors, Inc | 13 | $0 | 0.00% |
Sold out (1)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| AIGH Capital Management LLC | 17,235 | $141.0K |